tacrolimus
tacrolimus is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including Tacrolimus, tacrolimus. Available dosage forms: ointment, powder, capsule.
Drug details
- Generic Name
- tacrolimus
- Brand Names
- Tacrolimus, tacrolimus
- Application Number
- ANDA200744
- Sponsor
- E. Fougera & Co. A Division Of Fougera Pharmaceuticals, LLC
- NDC Codes
- 10
- Dosage Forms
- OINTMENT, POWDER, CAPSULE
- Routes
- TOPICAL, ORAL
- Active Ingredients
- TACROLIMUS
Indications and Usage
1 INDICATIONS AND USAGE Tacrolimus capsules are a calcineurin-inhibitor immuno-suppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, or heart transplants, in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection, in adult and pediatric patients receiving allogeneic kidney transplant [see Clinical Studies ( 14.1 )], liver transplants [see Clinical Studies ( 14.2 )], or heart transplant [see Clinical Studies ( 14.3 )], in combination with other immunosuppressants.